Personal defibrillator gains CE certification
01 June, 2021Sydney-based medical device start-up RRR has secured European regulatory approval for its personal automated external defibrillator (AED), CellAED.
PBS-listed progesterone pessary slashes preterm birth risk
31 May, 2021A vaginal progesterone pessary is reported to be the first progesterone treatment to be reimbursed via the PBS for the prevention of preterm birth.
Metabolic hormone leptin linked to vaccine response
31 May, 2021 by Amy SarcevicReduced levels of the metabolic hormone leptin may be responsible for poor vaccine efficacy among certain individuals, according to a new study.
Infant pain-monitoring device gains international approval
28 May, 2021The smartphone-based pain assessment application has potential for use in children's hospitals, in postnatal wards, and among parents and other healthcare professionals.
Rising temperatures could lead to more stillbirths, study finds
28 May, 2021Early research suggests that climate change could lead to more stillbirths.
Last chance for aged-care providers to claim free PainChek licence
20 May, 2021This fortnight is the last chance for aged-care facilities to participate in the government-subsidised rollout of a complete point-of-care solution for best practice pain management.
New COVID-19 vaccine completely blocks viral transmission
19 May, 2021 by Amy SarcevicAn Adelaide-based company has developed a COVID-19 vaccine that completely blocks viral transmission to individuals who lack immunity, as well as offering protection for those inoculated.
Tech restores lives of those in chronic pain
19 May, 2021The Avalon Study has demonstrated the life-changing benefits of a closed-loop spinal cord stimulation system in patients with chronic, intractable pain.
COVID-19 antiviral treatment developed in Qld
18 May, 2021Australian and US researchers have developed an experimental direct-acting antiviral therapy to treat COVID-19.
New cancer centre to offer cutting-edge radiation therapy services
14 May, 2021A state-of-the-art cancer centre is scheduled to open within Holmesglen Private Hospital in September this year, offering the latest in advanced radiation therapy.
Genomics industry making headlines at HealthData21
14 May, 2021 | Supplied by: AIDH - Australasian Institute of Digital HealthGenomics is the focus for the first day of the annual health data conference of the Australasian Institute of Digital Health (AIDH), HealthData21.
Kirby Institute modelling could assist pandemic exit strategy
13 May, 2021UNSW's Kirby Institute has used mathematical modelling to test the effectiveness of different vaccination strategies for controlling the COVID-19 pandemic.
Breast implant cancer risk warning
11 May, 2021Victorian women who have undergone breast implant or breast reconstructive procedures are being encouraged to watch for early symptoms of a rare form of cancer.
Historic PBS listing of cannabis for Dravet syndrome
10 May, 2021Epidyolex has been added to the Pharmaceutical Benefits Scheme (PBS) for the treatment of Dravet syndrome, a rare and drug-resistant form of epilepsy.
Softmed begins sterilisation wrap production to ensure local supply
07 May, 2021One million sterilisation wraps will be produced each month in response to a critical worldwide shortage that threatens surgery cancellations in Australia.
